New patent for Teva AUSTEDO branded drug – DrugPatentWatch
Annual Drug Patent Expiration for AUSTEDO
Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from a single supplier. There are nine patents protecting this drug.
AUSTEDO drug price trends.
Drug patent litigation for AUSTEDO.
This drug has thirty-four patent family members in twenty-three countries.
The generic ingredient in AUSTEDO is signrabenazine. One registered supplier for this compound. Additional details are available on the deutetrabenazine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New Patent for the Teva AUSTEDO Branded drug
